Linked Life Data

11721493

Source:http://linkedlifedata.com/resource/pubmed/id/11721493

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
31 Pt 1
pubmed:dateCreated
2001-11-27
pubmed:abstractText
This pharmacoeconomic study was conducted to determine the cost of using tinzaparin, a low-molecular-weight heparin (LMWH), administered intravenously, in comparison with non-fractionated heparin (NFH) for the treatment of acute pulmonary embolism (PE) in France.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0755-4982
pubmed:author
pubmed:issnType
Print
pubmed:day
27
pubmed:volume
30
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1539-48
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2001
pubmed:articleTitle
[Economic assessment of the use of tinzaparin in the treatment of acute pulmonary embolism in France].
pubmed:affiliation
NERA Londres, 15 Stratford Place, Londres WIN 9AF, Royaume-Uni.
pubmed:publicationType
Journal Article, English Abstract, Research Support, Non-U.S. Gov't